NCT02675075View on ClinicalTrials.gov

DESIPHER_Speech Degradation as an Indicator of Physiological Degeneration in ALS

CompletedOBSERVATIONAL
Enrollment

34

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Amyotrophic Lateral Sclerosis
Trial Locations (1)

33612

James A. Haley Veterans' Hospital, Tampa, FL, Tampa

All Listed Sponsors
collaborator

Florida Institute for Human and Machine Cognition

OTHER

lead

VA Office of Research and Development

FED

NCT02675075 - DESIPHER_Speech Degradation as an Indicator of Physiological Degeneration in ALS | Biotech Hunter | Biotech Hunter